Medicine
Ivermectin 6 mg tablet
Ivermectin 6 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at temperatures below 30°C (86°F).
Key facts
- Active ingredient (INN)
- Ivermectin
- Brand
- Sold under the generic name
- Strength
- 6 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 10 blister pack, 30 tablets, 2 blister pack
- Manufacturer
- Advagen Pharma
- Origin register
- US FDA, United States
- Storage
- Store at temperatures below 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AX22 Ivermectin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 January 2025
- Identifiers
- RxCUI 199998, 311207DailyMed set ID e88adfbc-e375-4fea-827e-6ec51ed6fd0aNDC 72888-207Application ANDA215922
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 72888-207-09 | Advagen Pharma | 22 January 2025 |
| 30 tablet in 1 bottle | 72888-207-30 | Advagen Pharma | 22 January 2025 |
| 2 blister pack in 1 carton / 10 tablet in 1 blister pack | 72888-207-66 | Advagen Pharma | 22 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 November 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ivermectin
Clinical summary
Ivermectin is an antiparasitic indicated for the treatment of infections, among other approved uses. It is available as tablets and cream for oral and topical use. MedsAcross supplies Ivermectin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IvermectinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- STROMECTOL prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
Need Ivermectin 6 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.